期刊文献+

BP1基因在甲状腺癌组织中的表达及其临床意义

Clinical significance of BP1 gene expression in human thyroid cancer
原文传递
导出
摘要 目的检测BP1在甲状腺癌组织中的表达,探讨其与甲状腺癌临床病理因素的关系。方法运用原位杂交及免疫组化方法检测60例甲状腺癌组织(研究组)和20例正常甲状腺组织(对照组)中的BP1表达。结果原位杂交方法检测BP1mRNA阳性率在研究组中为78.3%(47/60),对照组中为20%(4/20),BP1基因在2组的表达差异有统计学意义(x。=22.09,P〈0.05);甲状腺癌各病理类型的阳性表达率分别为乳头状癌81.7%(40/49)、滤泡状癌85.7%(6/7)、髓样癌25.0%(1/4);髓样癌分别与乳头状癌、滤泡状癌之间BP1mRNA的表达差异有统计学意义(,=4.21,P〈0.05);免疫组化检测研究组中BP1蛋白阳性率为93.3%(56/60),对照组中BP1蛋白阳性率为10.0%(2/20),2组间BP1的表达差异有统计学意义(χ2=52.25,P〈0.05)。国际抗癌联盟(UICC)Ⅰ~Ⅱ期BP1mRNA阳性率90.9%(40/44),Ⅲ~Ⅳ期43.8%(7/16),差异有统计学意义(χ2=12.72,P〈0.05)。但BP1mRNA表达与性别、年龄及淋巴结转移无相关性。结论BP1在甲状腺癌组织中的表达显著上调;BP1基因的表达与其UICC分期、病理学类型有关,而与年龄、性别及淋巴转移无关。 Objective To detect the expression of BP1 gene in thyroid cancer and its relationship with clinicopathological features of thyroid cancer. Methods BP1 gene expression in 60 cases of thyroid cancer tis- sues and 20 cases of normal thyroid tissues were detected by in situ hybridization and immunohistoehemistry. Results The positive expression rate of BP1 mRNA was 78.3% (47/60) in the 60 cases of thyroid cancer tissues while it was 20% (4/20) in the 20 cases of normal thyroid tissues detected by in situ hybridization. The difference had statistical significance (P 〈 0. 05 ). Of the 3 pathological types of thyroid cancer, the positive expression rate of papillary carcinoma was 81.6% (40/49), follicular carcinoma 85.7% (6/7), and medullary carcinoma 25.0% (1/4). The expression of BP1 mRNA had statistical difference between medullary carcinoma and other pathological types like papillary carcinoma and follicular carcinoma ( P 〈 0. 05 ). The positive expression rate of BP1 protein was 93.3 % (56/60)in the 60 cases of thyroid cancer tissues while it was 10. 0% (2/20)in the 20 cases of normal thyroid tissues detected by immunohistochemistry. The difference had statistical significance(P 〈 0. 05). Conclusion BP1 gene expression is up-regulated in human thyroid cancer and it is related to tumor stage and pathological type but not related to patients' age, sex or lymph node metastasis.
出处 《中华内分泌外科杂志》 CAS 2013年第3期218-220,共3页 Chinese Journal of Endocrine Surgery
基金 陕西省科学技术研究发展计划项目(2010k01-136)
关键词 甲状腺癌 BP1基因 原位杂交 免疫组化 Thyroid cancer BP1 gene In situ hybridization Immunohistochemistry
  • 相关文献

参考文献12

  • 1张笑男,陈光,马丽霞.Fascin蛋白在分化型甲状腺癌中的研究[J].内蒙古民族大学学报(自然科学版),2009,24(1):103-104. 被引量:4
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J] . CA CancerJ Clin, 2009 ,59 ( 4 ) : 225 -249.
  • 3Fu SW, Schwartz A, Stevenson H, et al. Correlation of expression of BPI, a homeobox gene, with estrogen receptor status in breast canc?err 1] . Breast Cancer Res ,2003 ,5 (4) : R82-R87.
  • 4Kluk BJ, Fu Y, Formolo TA, et al. BPI, an isoform of DLX4 ho?meoprotein, negatively regulates BRCAI in sporadic breast cancer[J]. IntJ Bioi Sci ,2010 ,6(5) :513-524.
  • 5Fu Y, Lian Y, Kim KS, et aI. BPI homeobox gene, correlates withbreast cancer progression and invasion[J]. Breast Cancer Res, 2005, 90( 3) :241-247.
  • 6Cavalli LR, Man YG, Schwartz AM, et aI. Amplification of the BPI homeobox gene in breast cancer[J] . Cancer Genet Cytogent, 2008,187 (1) : 19-24.
  • 7Zoueva OP, Garrett W, Bodine D, et al. BPI motif in the human beta-globin promoter affects beta-globin expression during embry?onic/fetal erythropoiesis in transgenic mice bearing the human be?ta-globin gene[J]. Blood Cells Mol Dis,2008,41(3) :244-251.
  • 8Ferrari N ,Paleari L,Palmisano GL,et al. Induction of apoptosis by fenretinide in tumor cell lines correlated with DLX-2, DLX-3 and DLX-4 gene expression[J]. Oncol Rep, 2003, 10( 4) : 973-977.
  • 9Haga SB, Fu S, KarpJE, et aI. BPI, a new homeobox gene, is fre?quently expressed in acute leukemias[J]. Leukemia, 2004, 14 (11): 1867-1875.
  • 10Man YG, Fu SW, Schwartz A, et aI. Expression of BPI, a novel homeoprotein enhances metastatic potential in ER -negative breast cancer] 1]. Cancer, 2010,1 (1 ) :54-62.

二级参考文献9

  • 1陈璐璐.甲状腺结节的病因和诊治研究进展[J].临床内科杂志,2004,21(6):368-370. 被引量:21
  • 2Tuhb BE,Mulholand DJ.Testis fascin (FSCN3):A noval paralog of the actin-bunding protein fascin expressed specifically in the elongate spermatid head [J].Experimental Cell Research,2002,275:92-109.
  • 3De Atcangelis A,Georges-Labouesse E,Adams J C.Expression of fascin-l,the gene encoding the actin-bunding protein fascin- 1,during mouse embryogenesis [J].Gene expression patterns,2004,4:637-643.
  • 4BryanJ,kene RE.Separation and interaction of the major component of sea urchin actin gel [J].J Mol Biol,1978,125(2) : 207-224.
  • 5Adams JC ,Clalland JD,Collell GD,et al.Cell matrix adhesions differentially regulate fascin phosphorylation [J].Mol Biol Cell, 1999,10(12):4177-4190.
  • 6Pelosi G,Pastorino U,Pasini F,et al.Independent prognostic value of fascin immunoreactivity in stag Ⅰ non-small cell lung cancer[J].British Journal of Cancer,2003,88:537-547.
  • 7Swicrezynski SL,Maitra A,Abraham SC,et al.Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays [J] .Human Pathology,2004,35:357-366.
  • 8Grothey A,Hashizume R,Sahhim AA,et al.Fascin,an acting-bunding protein associated with cell motility,is upregulated in hormone receptor negtive breast carcer[J].British Journal of Carcer.2000,83:870-873.
  • 9Chen Guang, Zhang Fa-Ren, Ren Jiang,et al.Expression of fascin in thyroid neoplasms:a novel diagnostic marker[J]. Cancer Res Clin Oncol, 2008,134:947-951.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部